EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
Contributeurs/tricesSmolen, Josef S![orcid](assets/images/orcid.png)
; Landewé, Robert B M![orcid](assets/images/orcid.png)
; Bergstra, Sytske Anne![orcid](assets/images/orcid.png)
; Kerschbaumer, Andreas![orcid](assets/images/orcid.png)
; Sepriano, Alexandre![orcid](assets/images/orcid.png)
; Aletaha, Daniel![orcid](assets/images/orcid.png)
; Caporali, Roberto; Edwards, Christopher John; Hyrich, Kimme L![orcid](assets/images/orcid.png)
; Pope, Janet E![orcid](assets/images/orcid.png)
; de Souza, Savia![orcid](assets/images/orcid.png)
; Stamm, Tanja A![orcid](assets/images/orcid.png)
; Takeuchi, Tsutomu![orcid](assets/images/orcid.png)
; Verschueren, Patrick![orcid](assets/images/orcid.png)
; Winthrop, Kevin L![orcid](assets/images/orcid.png)
; Balsa, Alejandro![orcid](assets/images/orcid.png)
; Bathon, Joan M; Buch, Maya H![orcid](assets/images/orcid.png)
; Burmester, Gerd R![orcid](assets/images/orcid.png)
; Buttgereit, Frank![orcid](assets/images/orcid.png)
; Cardiel, Mario Humberto; Chatzidionysiou, Katerina![orcid](assets/images/orcid.png)
; Codreanu, Catalin; Cutolo, Maurizio![orcid](assets/images/orcid.png)
; den Broeder, Alfons A; El Aoufy, Khadija; Finckh, Axel![orcid](assets/images/orcid.png)
; Fonseca, João Eurico![orcid](assets/images/orcid.png)
; Gottenberg, Jacques-Eric![orcid](assets/images/orcid.png)
; Haavardsholm, Espen A; Iagnocco, Annamaria![orcid](assets/images/orcid.png)
; Lauper, Kim![orcid](assets/images/orcid.png)
; Li, Zhanguo; McInnes, Iain B; Mysler, Eduardo F; Nash, Peter![orcid](assets/images/orcid.png)
; Poor, Gyula; Ristic, Gorica G; Rivellese, Felice![orcid](assets/images/orcid.png)
; Rubbert-Roth, Andrea![orcid](assets/images/orcid.png)
; Schulze-Koops, Hendrik![orcid](assets/images/orcid.png)
; Stoilov, Nikolay; Strangfeld, Anja![orcid](assets/images/orcid.png)
; van der Helm-van Mil, Annette; van Duuren, Elsa; Vliet Vlieland, Theodora P M![orcid](assets/images/orcid.png)
; Westhovens, René![orcid](assets/images/orcid.png)
; van der Heijde, Désirée![orcid](assets/images/orcid.png)
![orcid](assets/images/orcid.png)
![orcid](assets/images/orcid.png)
![orcid](assets/images/orcid.png)
![orcid](assets/images/orcid.png)
![orcid](assets/images/orcid.png)
![orcid](assets/images/orcid.png)
![orcid](assets/images/orcid.png)
![orcid](assets/images/orcid.png)
![orcid](assets/images/orcid.png)
![orcid](assets/images/orcid.png)
![orcid](assets/images/orcid.png)
![orcid](assets/images/orcid.png)
![orcid](assets/images/orcid.png)
![orcid](assets/images/orcid.png)
![orcid](assets/images/orcid.png)
![orcid](assets/images/orcid.png)
![orcid](assets/images/orcid.png)
![orcid](assets/images/orcid.png)
![orcid](assets/images/orcid.png)
![orcid](assets/images/orcid.png)
![orcid](assets/images/orcid.png)
![orcid](assets/images/orcid.png)
![orcid](assets/images/orcid.png)
![orcid](assets/images/orcid.png)
![orcid](assets/images/orcid.png)
![orcid](assets/images/orcid.png)
![orcid](assets/images/orcid.png)
![orcid](assets/images/orcid.png)
![orcid](assets/images/orcid.png)
![orcid](assets/images/orcid.png)
![orcid](assets/images/orcid.png)
![orcid](assets/images/orcid.png)
Publié dansAnnals of the rheumatic diseases, vol. 82, no. 1, p. 3-18
Errata
- The competing interests statement was erroneously omitted and is now included in the online version.
- DOI : 10.1136/ard-2022-223356corr1
- PMID : 36764818
Date de publication2023-01-10
Date de mise en ligne2022-11-10
Résumé
Mots-clés
- Antirheumatic Agents
- Arthritis, Rheumatoid
- Biological Therapy
- Antirheumatic Agents / therapeutic use
- Arthritis, Rheumatoid / chemically induced
- Arthritis, Rheumatoid / drug therapy
- Biological Products / therapeutic use
- Biosimilar Pharmaceuticals / therapeutic use
- Drug Therapy, Combination
- Humans
- Methotrexate / therapeutic use
- Neoplasms / drug therapy
Structure d'affiliation
Citation (format ISO)
SMOLEN, Josef S et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. In: Annals of the rheumatic diseases, 2023, vol. 82, n° 1, p. 3–18. doi: 10.1136/ard-2022-223356
Fichiers principaux (1)
Article (Published version)
![accessLevelPublic](assets/images/access-level-free.png)
Fichiers secondaires (1)
Correctifs (1)
Erratum
![accessLevelPublic](assets/images/access-level-free.png)
Identifiants
- PID : unige:169382
- DOI : 10.1136/ard-2022-223356
- PMID : 36357155
URL commercialhttps://ard.bmj.com/lookup/doi/10.1136/ard-2022-223356
ISSN du journal0003-4967